Press Release: Director's Dealings announcement according to --15a WpHG (the German Securities Trading Act)

MorphoSys AG / Director's Dealings announcement according to --15a WpHG (the German Securities Trading Act) . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

Details of the person subject to the disclosure requirement Name: Sproll, Marlies Person with executive functions: Member of a managing Professional role: body Details of the relationship: Chief Scientific Officer

Designation of the financial instrument ISIN: DE0006632003 Designation: Shares of MorphoSys AG

Details of the transaction Type of transaction: Purchase Date: 03.12.2014 Place (stock exchange): Frankfurt (XETRA) Price: 79.52396 Currency: EUR Quantity: 1250 Business volume: 99,404.95

Details of the company with the publishing obligation: Issuer: MorphoSys AG Lena-Christ-Str. 48 D-82152 Martinsried / Munich Germany

ISIN: DE0006632003 WKN: 663200

This announcement is distributed by Nasdaq OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: MorphoSys AG via Globenewswire

HUG#1876509

--- End of Message ---

MorphoSys AG

Lena-Christ-Str. 48 Martinsried / Munich Germany

WKN: 663200;ISIN: DE0006632003;Index:TecDAX,CDAX,Prime All Share,TECH All Share,HDAX,MIDCAP;

Listed: Freiverkehr in Börse Stuttgart,

Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,

Freiverkehr in Börse Berlin,

Freiverkehr in Börse Düsseldorf,

Freiverkehr in Bayerische Börse München,

Freiverkehr in Niedersächsische Börse zu Hannover,

Prime Standard in Frankfurter Wertpapierbörse,

Regulierter Markt in Frankfurter Wertpapierbörse;

http://www.morphosys.com (END) Dow Jones Newswires

   December 03, 2014 12:00 ET (17:00 GMT)- - 12 00 PM EST 12-03-14